EDAP:NSD-EDAP TMS S.A. (USD)

EQUITY | Medical Distribution | NASDAQ Global Market

Last Closing

USD 7.1

Change

-0.20 (-2.74)%

Market Cap

USD 0.09B

Volume

0.18M

Analyst Target

USD 5.29
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Edap TMS SA is a holding company. The Company through its divisions HIFU and UDS,develops, produces and markets minimally invasive medical devices for urological diseases. Its divisions operate in Europe, the Americas, Asia and the rest of the world.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-27 )

Largest Industry Peers for Medical Distribution

Symbol Name Price(Change) Market Cap
HSIC Henry Schein Inc

N/A

USD 9.40B
PDCO Patterson Companies Inc

N/A

USD 2.31B
ZYXI Zynex Inc

N/A

USD 0.36B
YI 111 Inc

N/A

USD 0.09B
AHG Akso Health Group ADR

N/A

USD 0.09B
COSM Cosmos Health Inc.

N/A

USD 0.01B

ETFs Containing EDAP

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Distribution) Market Performance vs. Exchange (NASDAQ Global Market)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 34.47% 86% B+ 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 34.47% 86% B+ 87% B+
Trailing 12 Months  
Capital Gain -36.21% 43% F 24% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -36.21% 43% F 24% F
Trailing 5 Years  
Capital Gain 136.67% 83% B 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 136.67% 83% B 86% B+
Average Annual (5 Year Horizon)  
Capital Gain 34.36% 100% F 87% B+
Dividend Return 34.36% 100% F 87% B+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 73.36% 43% F 22% F
Risk Adjusted Return 46.84% 86% B+ 80% B-
Market Capitalization 0.09B 57% F 53% F

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Distribution) Ratio vs. Market (NASDAQ Global Market)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 7.20 40% 11%
Price/Book Ratio 4.19 43% 26%
Price / Cash Flow Ratio -16.06 100% 85%
Price/Free Cash Flow Ratio -14.58 100% 86%
Management Effectiveness  
Return on Equity -31.66% 57% 40%
Return on Invested Capital -26.73% 43% 31%
Return on Assets -11.30% 43% 32%
Debt to Equity Ratio 5.01% 100% 75%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector